Unilever’s leadership is optimistic about its enormously expanded hygiene business – both skin cleansing and home cleaning – inasmuch as it doubts that a full COVID-19 recovery is in sight. The firm launched hand sanitizers in 65 new markets in just five months, helping to offset plunging sales in other areas of its business that were heavily impacted by lockdowns around the world.
Unilever PLC’s hygiene business – both skin cleansing and home cleaning – grew by 26% in the firm’s fiscal 2020 second quarter, achieving 17% growth for the first half of the year with roughly €4bn in sales.
“We had a very small hand sanitizer business prior to the outbreak of COVID-19,” noted CEO Alan Jope in a...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
